EDHB is a pan-PHD inhibitor. References: Harnoss JM, Platzer LK, Burhenne J, Radhakrishnan P, Cai J, Strowitzki MJ, Weiss J, Ritter AS, Mollenhauer M, Schmidt T, Ulrich A, Haefeli WE, Schneider M. Prolyl Hydroxylase Inhibition Enhances Liver Regeneration Without Induction of Tumor Growth. Ann Surg. 2017 Apr;265(4):782-791. doi: 10.1097/SLA.0000000000001696. PubMed PMID: 28266966.

纯度：≥98%

CAS：3943-89-3